-+ 0.00%
-+ 0.00%
-+ 0.00%

Nurix Therapeutics Q2 EPS $(0.52) Beats $(0.75) Estimate, Sales $44.056M Beat $17.009M Estimate

Benzinga·07/09/2025 20:02:44
Listen to the news
Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.75) by 30.76 percent. This is a 26.76 percent increase over losses of $(0.71) per share from the same period last year. The company reported quarterly sales of $44.056 million which beat the analyst consensus estimate of $17.009 million by 159.02 percent. This is a 264.34 percent increase over sales of $12.092 million the same period last year.